Sanofi India Limited (SANOFI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sanofi India Limited (SANOFI) has a cash flow conversion efficiency ratio of 0.585x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs4.38 Billion ≈ $47.40 Million USD) by net assets (Rs7.49 Billion ≈ $81.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sanofi India Limited defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Sanofi India Limited - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Sanofi India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Sanofi India Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sanofi India Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
|
-0.073x |
|
Standard Lithium Ltd
V:SLI
|
-0.016x |
|
Daheng New Epoch Technology Inc
SHG:600288
|
0.025x |
|
Beijing Asiacom Information Technology Co.Ltd
SHE:301085
|
N/A |
|
Intelbras S.A. - Indústria de Telecomunicação Eletrônica Brasileira
SA:INTB3
|
0.150x |
|
Veken Elite
SHG:600152
|
0.045x |
|
Shanghai Haohai Biological Tech Co
SHG:688366
|
0.019x |
|
YCC CORP
KQ:232140
|
0.072x |
Annual Cash Flow Conversion Efficiency for Sanofi India Limited (2004–2025)
The table below shows the annual cash flow conversion efficiency of Sanofi India Limited from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see SANOFI company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Rs7.49 Billion ≈ $81.02 Million |
Rs4.51 Billion ≈ $48.76 Million |
0.602x | +12.23% |
| 2024-12-31 | Rs8.61 Billion ≈ $93.07 Million |
Rs4.62 Billion ≈ $49.91 Million |
0.536x | +136.29% |
| 2023-12-31 | Rs10.15 Billion ≈ $109.79 Million |
Rs2.30 Billion ≈ $24.92 Million |
0.227x | -27.38% |
| 2022-12-31 | Rs12.76 Billion ≈ $137.97 Million |
Rs3.99 Billion ≈ $43.12 Million |
0.313x | +24.47% |
| 2021-12-31 | Rs22.26 Billion ≈ $240.69 Million |
Rs5.59 Billion ≈ $60.43 Million |
0.251x | -12.94% |
| 2020-12-31 | Rs21.19 Billion ≈ $229.16 Million |
Rs6.11 Billion ≈ $66.09 Million |
0.288x | +70.83% |
| 2019-12-31 | Rs24.42 Billion ≈ $264.13 Million |
Rs4.12 Billion ≈ $44.59 Million |
0.169x | +0.20% |
| 2018-12-31 | Rs22.19 Billion ≈ $240.00 Million |
Rs3.74 Billion ≈ $40.44 Million |
0.168x | -21.53% |
| 2017-12-31 | Rs20.26 Billion ≈ $219.15 Million |
Rs4.35 Billion ≈ $47.05 Million |
0.215x | +15.52% |
| 2016-12-31 | Rs17.36 Billion ≈ $187.70 Million |
Rs3.23 Billion ≈ $34.89 Million |
0.186x | +41.87% |
| 2015-12-31 | Rs16.27 Billion ≈ $175.97 Million |
Rs2.13 Billion ≈ $23.05 Million |
0.131x | -26.53% |
| 2014-12-31 | Rs14.86 Billion ≈ $160.69 Million |
Rs2.65 Billion ≈ $28.65 Million |
0.178x | -11.89% |
| 2013-12-31 | Rs13.47 Billion ≈ $145.64 Million |
Rs2.73 Billion ≈ $29.48 Million |
0.202x | -14.90% |
| 2012-12-31 | Rs12.04 Billion ≈ $130.22 Million |
Rs2.86 Billion ≈ $30.97 Million |
0.238x | +29.53% |
| 2011-12-31 | Rs11.17 Billion ≈ $120.76 Million |
Rs2.05 Billion ≈ $22.17 Million |
0.184x | +42.45% |
| 2010-12-31 | Rs10.14 Billion ≈ $109.68 Million |
Rs1.31 Billion ≈ $14.14 Million |
0.129x | -12.71% |
| 2009-12-31 | Rs9.32 Billion ≈ $100.77 Million |
Rs1.38 Billion ≈ $14.88 Million |
0.148x | +2.28% |
| 2008-12-31 | Rs8.29 Billion ≈ $89.66 Million |
Rs1.20 Billion ≈ $12.95 Million |
0.144x | -1.97% |
| 2007-12-31 | Rs7.07 Billion ≈ $76.44 Million |
Rs1.04 Billion ≈ $11.26 Million |
0.147x | -27.73% |
| 2006-12-31 | Rs6.08 Billion ≈ $65.78 Million |
Rs1.24 Billion ≈ $13.40 Million |
0.204x | -32.31% |
| 2005-12-31 | Rs5.24 Billion ≈ $56.65 Million |
Rs1.58 Billion ≈ $17.05 Million |
0.301x | +77.53% |
| 2004-12-31 | Rs4.22 Billion ≈ $45.62 Million |
Rs715.33 Million ≈ $7.74 Million |
0.170x | -- |
About Sanofi India Limited
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targoci… Read more